Akèy › Maladi ren kwonik › Tennessee › Nashville
Etid klinik pou Maladi ren kwonik nan Nashville, TN
6 etid pou Maladi ren kwonik ap chèche patisipan nan sit nan ak bò kote Nashville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Ap rekriteFaz 3
- Research Site, Nashville
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
Ap rekriteFaz 3
- Vanderbilt University Medical Center, Nashville
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Ap rekriteFaz 3
- Knoxville Kidney Center Pllc, Brentwood · 9 mi lwen
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
Ap rekriteFaz 2
- Vanderbilt University Medical Center, Nashville
Empagliflozin Treatment in Kidney Transplant Recipients
Ap rekriteFaz 4
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage
Ap rekrite
- Vanderbilt University Medical Center, Nashville
Etid Maladi ren kwonik nan lòt vil
- New York City, NY17 etid
- Boston, MA15 etid
- Houston, TX15 etid
- Dallas, TX15 etid
- Philadelphia, PA15 etid
- Chicago, IL12 etid
- Orlando, FL11 etid
- Atlanta, GA10 etid
- Durham, NC9 etid
- Kansas City, MO9 etid
- San Antonio, TX8 etid
- Albuquerque, NM8 etid
Lòt etid nan Nashville
- Kansè Poumon ki pa ti selil97 etid
- Kansè nan tete81 etid
- Kansè Metastatik70 etid
- Kansè kolorektal69 etid
- Kansè (tout kalite)65 etid
- Kansè ovè49 etid
- Kansè pwostat43 etid
- Kansè poumon40 etid
- Karsinòm selil skuamèz tèt ak kou39 etid
- Kansè pankreyas39 etid
- Kansè Endomèt38 etid
- Melanom33 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.